PAA 4.88% 19.5¢ pharmaust limited

The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst, page-654

  1. 562 Posts.
    lightbulb Created with Sketch. 98
    That call may be well "on the monepantel," but we know there are other potential purposes for this already repurposed medication, and I reckon (hope), MT and crew won't accept so low!
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.